T1 Energy Applauds Polysilicon Minimum Price, But Financing Hurdles Remain

What happened

T1 Energy issued a press release supporting a Trump Administration Section 232 proclamation that sets a minimum import price on polysilicon and derivative products, a move it says will strengthen U.S. solar manufacturing and prevent market manipulation. This regulatory tailwind aligns with T1's domestic sourcing strategy, but does not alter the company's immediate challenge: securing comprehensive financing for its $510 million G2 Austin cell factory, where first production has already slipped to Q1 2027. While the policy helps the long-term competitive landscape, the stock still trades on execution and funding milestones, with the balance sheet showing pressured liquidity and a $135 million Evervolt obligation due soon. Management's supportive statement is expected but should not distract from the fact that project financing remains unfiled and dilution risks persist. As such, the WAIT rating holds until a clear funding solution emerges.

Implication

The proclamation reinforces the domestic manufacturing moat but doesn’t fund the factory. T1’s ability to reach first cell production on time and on budget depends on closing a comprehensive financing package, not on policy statements. Investors should treat this as incremental confirmation of the industry tailwind already reflected in the stock price, rather than a catalyst to re-rate. The next key checkpoints are the Evervolt installment settlements in September–October 2026 and any disclosure of project debt or equity raises. Until those are clear, the risk of dilution and delay keeps the stock in a WAIT range.

Thesis delta

The investment thesis remains unchanged; the Section 232 proclamation supports the domestic solar narrative but does not address the critical financing and execution risks that define the current WAIT rating. No shift in valuation or conviction is warranted.